DISCUSSION  by unknown
Endovascular treatment of popliteal and tibial artery occlu-
sions is evolving, which is critical given the high prevalence
of disease found in these arterial segments. It was encour-
aging to see that most patients with advanced tibial disease
had at least one tibial occlusion that was short in length and
potentially more amenable to endovascular therapy. How-
ever, the tibial anatomy in CLI also demonstrates that
surgical bypass in these patients will likely always have a
role.
This study showed that more than half of patients with
CLI who are receiving an infrainguinal revascularization
procedure have arterial occlusive disease at the popliteal or
tibial arterial segments, with associated critical stenoses
involving the femoral artery segments. This trend is even
more pronounced in patients afflicted by DM, ESRD, or in
those who present with Fontaine stage IV. Selection bias
and study design likely affected these results. Future re-
search should focus on studying the global CLI population
and not just large subgroups. In addition, researchers con-
ducting angiogenesis trials and evaluating infrainguinal en-
dovascular techniques must strive to develop effective ther-
apies for popliteal and tibial artery occlusions.
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DISCUSSION
Dr Abou-Zamzam (Loma Linda, Calif). Thank you, Mr
President, members, and guests. I would like to congratulate the
authors on a nice presentation and an excellent accompanying
manuscript. The authors have provided a relatively large retrospec-
tive study on the distribution of arterial lesions in patients under-
going revascularization for critical limb ischemia. They have found
that when separating the arterial tree into these three groupings—
aortoiliac, femoral, and popliteal tibial—overall about 55% of the
patients with critical limb ischemia had occlusions isolated to the
popliteal tibial segments. This proportion was even greater, nearly
60% to 70%, in their patients with diabetes, end-stage renal disease,
and Fontaine class IV ischemia.
I have several questions for the authors, and keep in mind
some of these questions arise from the manuscript as well as from
the presentation today. The authors have collected data on occlu-
sions as well as stenoses and here they present their data primarily
on occlusions. The first series of related questions focus on this
issue. Could you provide us information on the combined presence
of occlusions and stenoses? It seems a little artificial to exclude
people—to say people do not have femoral disease if they really
have a stenosis of 80% to 99% and multilevel stenoses may be
hemodynamically more significant than short segment occlusions.
While the patients with popliteal tibial occlusions were free of more
proximal occlusions, were all these patients free of these high-grade
stenoses? And also, wouldn’t popliteal and tibial disease really be
multilevel? I mean it gets a little bit confusing when you talk about
single-level and multilevel disease.
Number 2, in the study of 450 patients, over 39% of the
patients did not have diabetes. Did the authors look specifically at
the patterns of disease in patients with diabetes and compare that
with the patients without diabetes, not just with occlusions but also
in regards to the stenoses?
And number 3, all these patients underwent revascularization.
Did the authors collect any information on those patients who
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underwent arteriography and subsequently ended up with primary
amputations instead of revascularization? Are there disease patterns
that are different in these most severely affected patients?
Once again, I enjoyed the presentation and the manuscript
very much. Thanks.
Dr Rueda. Thank you, Dr Abou-Zamzam. First question, to
simplify reporting the data we decided to make the most severe
lesion the dominant lesion within the arterial segment. For exam-
ple, if the proximal SFA contained a stenosis but then the middle
SFA contained an occlusion, then we classified that artery as being
occluded. Most diseased arteries had a combination of occlusions
and stenosis, but we did not analyze all lesions within the artery.
Our purpose was to describe the anatomical location of the occlu-
sions, as they seem more relevant to the design of novel endovas-
cular or even angiogenesis trials.
Two-thirds of patients with pop-tib occlusions had associated
critical stenoses present in the proximal arterial segments. The
remaining patients with pop-tib occlusions had associated subcriti-
cal stenoses in these arterial segments. Finally, analyzing the pat-
terns of proximal stenoses in patients with pop-tib occlusions based
on Fontaine stage, DM, or ESRD either showed no difference or
had few numbers in the subgroups to make meaningful compari-
sons.
Second question: Approximately 40% of the nondiabetic pop-
ulation had isolated involvement of the pop-tib segment compared
with roughly 60% of our diabetic patients.
Final question: We did not collect angiogram data on patients
who underwent treatment for CLI with major amputation for
practical reasons. Some of our patients who required a primary
amputation do not have an angiogram at our institution due to the
magnitude of their foot lesion. In addition, we decided to focus on
patients who underwent revascularization procedures because
these data are part of a larger database that would be used to report
outcomes of patients undergoing bypass vs endovascular proce-
dures. Eliminating the subset of patients who underwent a primary
amputation for CLI is a problem because these patients, we sus-
pect, are different. In addition from a clinical standpoint, these
patients are the ones who are often enrolled in CLI studies because
of the lack of revascularization options. This is an interesting
question that we will pursue in future endeavors.
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